Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Histone H2B type 1-O (encoded by the *HIST1H2BO* gene, commonly abbreviated as H2BC17) is a core nuclear protein that forms part of the nucleosome, which packages and organizes DNA into chromatin in eukaryotic cells. Two molecules each of histones H2A, H2B, H3, and H4 assemble into an octamer, around which DNA coils to form the nucleosome, the fundamental repeating unit of chromatin structure. Histone H2B type 1-O is essential for nucleosome assembly and thus participates in regulating DNA accessibility for transcription, replication, and repair, contributing to genomic integrity and chromosomal stability. H2BC17 is not considered a classical therapeutic target such as a receptor or enzyme and has no direct drug interactions or use as a clinical biomarker[1][2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Histone H2B type 1-O (H2BC17).